Back to Search
Start Over
A case of improvement of clozapine-induced low leukocyte counts by adenine, cepharanthin and ninjin-yoei-to in a patient with treatment-resistant schizophrenia
- Source :
- Journal of Pharmaceutical Health Care and Sciences, Vol 7, Iss 1, Pp 1-6 (2021), Journal of Pharmaceutical Health Care and Sciences
- Publication Year :
- 2021
- Publisher :
- BMC, 2021.
-
Abstract
- Background Although clozapine is the optimal drug for patients with treatment-resistant schizophrenia, the drug has harmful adverse effects such as leukopenia. Adenine and cepharanthine are known to be effective for radiation- or drug-induced leukopenia. Furthermore, ninjin-yoei-to, a Chinese herbal medicine, augments the production of granulocyte-macrophage colony-stimulating factor. Thus, these drugs may be useful for clozapine-induced leukopenia. Case presentation A 21 years-old woman with schizophrenia was hospitalized for initiation of clozapine treatment. Despite concomitant use of adenine, cepharanthine, and lithium carbonate having activities of increasing leukocytes, a decrease in leukocyte counts occurred after the initiation of clozapine. Additional administration of ninjin-yoei-to increased leukocyte counts, which prevented the development of leukopenia. Conclusions This is the first case that concomitant use of adenine, cepharanthin, and ninjin-yoei-to exhibited the effectiveness of reversing the decrease in leukocytes caused by clozapine. Monitoring leukocyte counts and preventing leukopenia are essential for successful treatment with clozapine for refractory schizophrenia. These medicines may be a potential option for preventing clozapine-induced leukopenia.
- Subjects :
- Drug
media_common.quotation_subject
Treatment-resistant schizophrenia
Case Report
Pharmacology (nursing)
RM1-950
Pharmacology
chemistry.chemical_compound
Pharmacotherapy
Pharmacy and materia medica
medicine
Cepharanthine
Pharmacology (medical)
Adverse effect
Clozapine
media_common
Leukopenia
business.industry
Ninjin-yoei-to
medicine.disease
RS1-441
chemistry
Schizophrenia
Concomitant
Therapeutics. Pharmacology
medicine.symptom
business
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 20550294
- Volume :
- 7
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Journal of Pharmaceutical Health Care and Sciences
- Accession number :
- edsair.doi.dedup.....50e5ffdb7c8fc5d193eeeaa139a6b988